期刊文献+

肝素钠肺泡灌洗治疗ALI/ARDS的临床疗效观察 被引量:3

Aclinical study on acute lung injury/acute respiratory distress syndrome treated with the unfraetioned heparin bronchial alveolar lavage
下载PDF
导出
摘要 目的探讨肝素钠(UFH)肺灌洗治疗急性肺损伤的临床疗效及可能的作用机制。方法选择120例急性肺损伤,急性呼吸窘迫综合征(AL姒RDS)的患者,随机分为对照组、肝素肺泡灌洗组和肝素雾化组。对照组:使用常规治疗基础上行生理盐水肺灌洗;肝素肺泡灌洗组:常规治疗基础上行肝素钠盐水肺灌洗;肝素雾化组:在常规治疗基础上行气道雾化吸人肝素钠。观察和比较3组患者治疗7d后氧合指数、急性生理学号陧性健康状况Ⅱ(APACHEI/)评分、肺泡灌洗液(BALF)中IL-6以及PLT、APTT变化、7d死亡率。结果各组治疗7d后各项指标较前有好转,肝素肺泡灌洗组和肝素雾化组较对照组氧合指数(OI)明显升高,P〈0.01,BALF中的IL-6、APACHEⅡ评分下降显著。其中,肝素肺泡灌洗组氧合指数优于肝素雾化组,而IL-6、APACHEⅡ评分较雾化组低,P〈0.05。肝素肺泡灌洗和肝素雾化治疗后PLT、APT与对照组比较无差异。肝素肺泡灌洗组、肝素雾化组、对照组死亡率分别为7.5%,12.5%,26.8%,差异有统计学意义,肝素肺泡灌洗组和肝素雾化组死亡率低于对照组,P〈0.05。结论肝素肺灌洗和肝素雾化吸入治疗ALI/ARDS,能够改善氧合;抑制IL-6等炎症介质的释放,降低炎症反应,从而降低患者的死亡率。 Objective To investigate the effect and possible mechanism bronchial alveolar lavage with unfractioned heparin in ALI/ARDS patients. Methods A total of 120 ALI/ARDS patients were randomly divided into control group, BAL group, and atomizationg group. Patients in the control group were treated with routine therapy, while patients in BAL group and atomization group respectively received unfractionated heparin bronchial alveolar lavage and ultrasonic atomizing inhalation of unfractionated heparin on top of the routine therapy. The three groups with 7 days of oxygen index, APACHE Ⅱ scores, IL-6 level of BALF, and PLT, APTT change, and 7 days mortality were observed and compared. Results The 7-day indexes reflected a better result in all three groups, and anticoagulation group (BAL group and atomization group) was better than control group. The oxygen of BAL group was better than that of atomization group, while BALF IL-6 level and APACHE Ⅱ scores of BAL group were lower than those of atomization group. PLT and APTT of the three groups had no significant difference before and after the treatments was offered. Mortality rates of BAL group, atomizationg group, and control group were 7.5%, 12.5%, and 26.8%, respectively. Difference was found among the three groups. Antieoagulation group was better than control group. Conclusion It was proved that UFH bronchial alveolar lavage resulted in activating fibrinolysis system and improving ventilate function, lowering local eoagulability, and inhibiting the release of IL-6, reducing the systemic inflammation, which is considered being effective eventually reducing mortality of the patients.
出处 《中国急救复苏与灾害医学杂志》 2014年第1期49-52,共4页 China Journal of Emergency Resuscitation and Disaster Medicine
关键词 肝素钠 肺泡灌洗 急性肺损伤 急性呼吸窘迫综合征 Unfractionated heparin Bronchial alveolar lavage ALI/ARDS
  • 相关文献

参考文献5

二级参考文献61

  • 1樊毫军,刘书盈,张健鹏,刘又宁.静脉注射内毒素致大鼠急性肺损伤模型的病理生理学指标评价[J].中国危重病急救医学,2006,18(8):485-487. 被引量:20
  • 2Fatma Ayca Gultekin,Mustafa Kerem,Ertan Tatlicioglu,Aysel Aricioglu,Cigdem Unsal,Neslihan Bukan.Leptin treatment ameliorates acute lung injury in rats with cerulein-induced acute pancreatitis[J].World Journal of Gastroenterology,2007,13(21):2932-2938. 被引量:24
  • 3Camerer E,KolqdstΦ AB,Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res,1996,81(1) :1-41.
  • 4Osterud B. Tissue factor expression by monocytes: regulation and pathophysiological roles. Blood Coagul Fibrinolysis,1998,9(Suppl 1) :S9-14.
  • 5LupuC, Westmuckett AD, PeerG, et al. Tissue factor dependent coagulation is preferentially up-regulated with+ in arterial branching areas in a baboon model of Eseherichia coli sepsis. Am J Pathol,2005,167(4):1161-1172.
  • 6Brogan PA, Dillon MJ. Endothelial microparticles and the diagnosis of the vasculitides. Intern Med,2004,43(12) : 1115-1119.
  • 7Nieuwland R,Berckmans RJ,McGregor S, et al. Cellular origin and procoagulant properties of mieroparticles in meningococcal sepsis. Blood, 2000, 95(S):930-935.
  • 8Hamihon KK, Hattori R, Esmon CT, et al. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of tee prothrombinase enzyme complex. J Biol Chem, 1990,265(7):3809-3814.
  • 9Combes V,Simon AC,Grau GE,et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest, 1999, 104 (1):93-102.
  • 10Zielinski T, Wachowicz B, Saluk- Juszczak J,et al. Polysaccharide part of Proteus mirabilis lipopolysaccharide may be responsible tor the stimulation of platelet adhesion to collagen. Platelets, 2002,13 (7) : 419- 424.

共引文献86

同被引文献61

  • 1Blank R, Napolitano LM. Epidemiology of ARDS and ALI. Crit Care Clin, 2011,27(3):439-458.
  • 2Iscimen R, Cartin-Ceba R, Yilmaz M, et al. Risk factors for the development of acute lung injury in patients with septic shock: an observational cohort study. Crit Care Med,2008,36(5):1518-1522.
  • 3ARDS Definition Task Force.Acute respiratory distress syndrome: the Berlin Definition. JAMA, 2012,307(23):2526-2533.
  • 4Marshall RP, Webb S, Hill MR, et al. Genetic polymorphisms associated with susceptibility and outcome in ARDS . Chest, 2002, 121(3): 68-69.
  • 5Kushimoto S, Taira Y, Kitazawa Y, et al. The clinical usefulness of extravascular lung water and pulmonary vascular permeability index to diagnose and characterize pulmonary edema: a prospective muhicenter study on the quantitative differential diagnostic definition for acute lung injury/ acute respiratory distress syndrome. Crit Care, 2012,16(6):232.
  • 6Jozwiak M, Silva S, Persichini R, et al. Extravascular lung water is an independent prognostic factor in patients with acute respiratory distress syndrome. Crit Care Med,2013,41(2):472-480.
  • 7Caser EB, Zandonade E, Pereira E, et al. Impact of distinct definitions of acute lung injury on its incidence and outcomes in Brazilian ICUs: prospective evaluation of 7,133 patients'. Crit Care Med, 2014, 42(3): 574-582.
  • 8Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med, 1994, 149(3):818-824.
  • 9Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med, 2005, 353(16): 1685-1693.
  • 10Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity, 2014, 40(3): 315-327.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部